Literature DB >> 21646576

An effectiveness trial of group cognitive behavioral therapy for patients with persistent depressive symptoms in substance abuse treatment.

Katherine E Watkins1, Sarah B Hunter, Kimberly A Hepner, Susan M Paddock, Erin de la Cruz, Annie J Zhou, Jim Gilmore.   

Abstract

CONTEXT: Although depression frequently co-occurs with substance abuse, few individuals entering substance abuse treatment have access to effective depression treatment.
OBJECTIVE: The Building Recovery by Improving Goals, Habits, and Thoughts (BRIGHT) study is a community-based effectiveness trial that compared residential substance abuse treatment with residential treatment plus group cognitive behavioral therapy for depression delivered by substance abuse treatment counselors. We hypothesized that intervention clients would have improved depression and substance use outcomes compared with those of clients receiving usual care.
DESIGN: A nonrandomized controlled trial using a quasi-experimental intent-to-treat design in which 4 sites were assigned to alternate between the intervention and usual care conditions every 4 months for 2½ years.
SETTING: Four treatment programs in Los Angeles County. PARTICIPANTS: We screened 1262 clients for persistent depressive symptoms (Beck Depression Inventory-II score >17). We assigned 299 clients to receive either usual care (n = 159) or usual care plus the intervention (n = 140). Follow-up rates at 3 and 6 months after the baseline interview were 88.1% and 86.2%, respectively, for usual care and 85.7% and 85.0%, respectively, for the intervention group. INTERVENTION: Sixteen 2-hour group sessions of cognitive behavioral therapy for depression. MAIN OUTCOME MEASURES: Change in depression symptoms, mental health functioning, and days of alcohol and problem substance use.
RESULTS: Intervention clients reported significantly fewer depressive symptoms (P < .001 at 3 and 6 months) and had improved mental health functioning (P < .001 at 3 months and P < .01 at 6 months). At 6 months, intervention clients reported fewer drinking days (P < .05) and fewer days of problem substance use (P < .05) on days available.
CONCLUSIONS: Providing group cognitive behavioral therapy for depression to clients with persistent depressive symptoms receiving residential substance abuse treatment is associated with improved depression and substance use outcomes. These results provide support for a new model of integrated care. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01191788.

Entities:  

Mesh:

Year:  2011        PMID: 21646576      PMCID: PMC3230556          DOI: 10.1001/archgenpsychiatry.2011.53

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  42 in total

1.  A national survey of care for persons with co-occurring mental and substance use disorders.

Authors:  K E Watkins; A Burnam; F Y Kung; S Paddock
Journal:  Psychiatr Serv       Date:  2001-08       Impact factor: 3.084

Review 2.  Community-based intervention research: coping with the "noise" of real life in study design.

Authors:  Ann A Hohmann; M Katherine Shear
Journal:  Am J Psychiatry       Date:  2002-02       Impact factor: 18.112

3.  Assessing organizational readiness for change.

Authors:  Wayne E K Lehman; Jack M Greener; D Dwayne Simpson
Journal:  J Subst Abuse Treat       Date:  2002-06

4.  A multilevel modelling approach to analysis of patient costs under managed care.

Authors:  K Carey
Journal:  Health Econ       Date:  2000-07       Impact factor: 3.046

5.  Detecting bipolar disorder among treatment-seeking substance abusers.

Authors:  K L Sloan; D Kivlahan; A J Saxon
Journal:  Am J Drug Alcohol Abuse       Date:  2000-02       Impact factor: 3.829

6.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

7.  A psychometric evaluation of the BDI-II in treatment-seeking substance abusers.

Authors:  T C Buckley; J D Parker; J Heggie
Journal:  J Subst Abuse Treat       Date:  2001-04

8.  Effects of major depression on remission and relapse of substance dependence.

Authors:  Deborah Hasin; Xinhua Liu; Edward Nunes; Steven McCloud; Sharon Samet; Jean Endicott
Journal:  Arch Gen Psychiatry       Date:  2002-04

9.  Alcohol use disorders comorbid with anxiety, depression and drug use disorders. Findings from the Australian National Survey of Mental Health and Well Being.

Authors:  Lucy Burns; Maree Teesson
Journal:  Drug Alcohol Depend       Date:  2002-12-01       Impact factor: 4.492

10.  Dually diagnosed patients' responses to substance use disorder treatment.

Authors:  M Tyler Boden; Rudolf Moos
Journal:  J Subst Abuse Treat       Date:  2009-06-21
View more
  31 in total

1.  Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial.

Authors:  Matthew J Worley; Ryan S Trim; Scott C Roesch; Jennifer Mrnak-Meyer; Susan R Tate; Sandra A Brown
Journal:  J Subst Abuse Treat       Date:  2012-03-08

2.  Bayesian restricted spatial regression for examining session features and patient outcomes in open-enrollment group therapy studies.

Authors:  Susan M Paddock; Thomas J Leininger; Sarah B Hunter
Journal:  Stat Med       Date:  2015-08-13       Impact factor: 2.373

3.  Does group cognitive-behavioral therapy module type moderate depression symptom changes in substance abuse treatment clients?

Authors:  Susan M Paddock; Sarah B Hunter; Thomas J Leininger
Journal:  J Subst Abuse Treat       Date:  2014-03-01

4.  Bayesian models for semicontinuous outcomes in rolling admission therapy groups.

Authors:  Lane F Burgette; Susan M Paddock
Journal:  Psychol Methods       Date:  2017-12

Review 5.  Treatment of Adolescent Substance Use Disorders and Co-Occurring Internalizing Disorders: A Critical Review and Proposed Model.

Authors:  Leslie A Hulvershorn; Patrick D Quinn; Eric L Scott
Journal:  Curr Drug Abuse Rev       Date:  2015

6.  Bayesian Hierarchical Semiparametric Modelling of Longitudinal Post-treatment Outcomes from Open Enrolment Therapy Groups.

Authors:  Susan M Paddock; Terrance D Savitsky
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2013-06-01       Impact factor: 2.483

7.  Bayesian Semi- and Non-parametric Models for Longitudinal Data with Multiple Membership Effects in R.

Authors:  Terrance D Savitsky; Susan M Paddock
Journal:  J Stat Softw       Date:  2014-03       Impact factor: 6.440

8.  The cost-effectiveness of depression treatment for co-occurring disorders: a clinical trial.

Authors:  Katherine E Watkins; Alison E Cuellar; Kimberly A Hepner; Sarah B Hunter; Susan M Paddock; Brett A Ewing; Erin de la Cruz
Journal:  J Subst Abuse Treat       Date:  2013-10-02

9.  Community-partnered evaluation of depression services for clients of community-based agencies in under-resourced communities in Los Angeles.

Authors:  Jeanne Miranda; Michael K Ong; Loretta Jones; Bowen Chung; Elizabeth L Dixon; Lingqi Tang; Jim Gilmore; Cathy Sherbourne; Victoria K Ngo; Susan Stockdale; Esmeralda Ramos; Thomas R Belin; Kenneth B Wells
Journal:  J Gen Intern Med       Date:  2013-05-14       Impact factor: 5.128

10.  Reinforcing integrated psychiatric service attendance in an opioid-agonist program: a randomized and controlled trial.

Authors:  Michael Kidorf; Robert K Brooner; Neeraj Gandotra; Denis Antoine; Van L King; Jessica Peirce; Sharon Ghazarian
Journal:  Drug Alcohol Depend       Date:  2013-07-15       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.